Sir, Enterococci are increasingly recognized as important nosocomial pathogens, particularly as aetiological agents of nosocomial bloodstream infections. Vancomycin resistance among enterococci is an emerging nosocomial problem, leaving no therapeutic options in seriously ill patients. 1 In Greece, up to now, no significant vancomycin resistance has been reported, except by one study from northern Greece, 2 which reported a rate of 7.6%. We report the first nine cases of infections with Enterococcus faecium VanA isolates from February 1999 to March 2000 in our 900-bed tertiary hospital. Four isolates of vancomycin-resistant enterococci (VRE) were from blood, two from peritoneal fluid, two from surgical drainage sites and one from urine. Identification to species level and determination of MICs of several antibiotics were performed using the PASCO ID/MIC system for Gram-positive organisms (Difco Laboratories, Detroit, MI, USA). The MICs of vancomycin and teicoplanin were also determined by Etest. The MICs of vancomycin and teicoplanin were у256 and 128 mg/L, respectively. The phenotype of all E. faecium isolates was VanA. The results of the susceptibility testing are listed in the Table. Molecular strain typing was performed by pulsed-field gel electrophoresis (PFGE) and polymerase chain reaction (PCR) analysis. Genomic DNA of the above nine strains was isolated and cleaved by the restriction endonuclease SmaI. The DNA fragments were detected in 1% pulsed-field certified agarose (Bio-Rad Laboratories, Hercules, CA, USA) with a CHEF-DRIII system (BioRad). The voltage gradient was 6 V/cm. For the first 15 h, the pulse was 1-10 s and for the remaining 8 h it was 10-30 s. PFGE showed similar banding patterns (data not shown), so the VRE isolates were assumed to be related strains. The presence of van genes was detected by PCR, as proposed by Dutka-Malen et al. 3 Primers VAN A1 (5Ј-GCTATTCAGCTGTACTC-3Ј) and VAN A2 (5Ј-CAGCGGCCATCATACGG-3Ј) were used to amplify a 783 bp fragment of the vanA gene. A 1 kb DNA ladder (Gibco-BRL, Paisley, UK) was used as a size standard. The vanA gene was identified in all tested isolates (data not shown). In the USA, VRE strains reportedly accounted for Ͼ25% of all enterococci isolated in intensive care units, whilst most European countries have a low incidence of VRE strains. 5 In our hospital, we have noticed an increasing proportion of vancomycin-sensitive E. faecium strains during 1992-96. 6 These first cases of E. faecium with the VanA phenotype confirm the emergence of VRE infections in our hospital.
